カテゴリー： LP Information, 世界, 部品/材料

世界のフィルゴチニブ市場予測 2023年-2029年

◆英語タイトル：Global Filgotinib Market Growth 2023-2029
	◆商品コード：LP23JU3173 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：102 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のフィルゴチニブ市場」は、過去の販売実績から2022年の世界のフィルゴチニブの総販売量を検討し、2023年から2029年の予測されるフィルゴチニブの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のフィルゴチニブの市場規模を掲載し、XXX百万米ドル規模の世界のフィルゴチニブ市場の詳細な分析を提供します。本インサイトレポートは、世界のフィルゴチニブ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のフィルゴチニブ市場における各社の独自のポジションをより深く理解するために、フィルゴチニブ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のフィルゴチニブ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。フィルゴチニブの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。フィルゴチニブの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。フィルゴチニブのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

フィルゴチニブの世界主要メーカーとしては、Cayman Chemical、 BioVision、 Adooq Bioscience、 Taiclone、 Clearsynth、 Biorbyt、 APExBIO Technology、 Selleck Chemicals、 AbMole、 BOC Sciences、 TargetMol、 Toronto Research Chemicals、 J&K Scientificなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のフィルゴチニブ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではフィルゴチニブ市場をセグメンテーションし、種類別 (純度98%以下、純度98%～99%、純度99%以上)、用途別 (研究、医療)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度98%以下、純度98%～99%、純度99%以上

・用途別区分：研究、医療

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のフィルゴチニブ市場の10年間の市場状況・展望は？
・世界および地域別に見たフィルゴチニブ市場成長の要因は何か？
・フィルゴチニブの市場機会はエンドマーケットの規模によってどのように変化するのか？
・フィルゴチニブのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：フィルゴチニブの年間販売量2018-2029、地域別現状・将来分析
・フィルゴチニブの種類別セグメント：純度98%以下、純度98%～99%、純度99%以上
・フィルゴチニブの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・フィルゴチニブの用途別セグメント：研究、医療
・フィルゴチニブの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のフィルゴチニブ市場
・企業別のグローバルフィルゴチニブ市場データ：2018-2023年の年間販売量、市場シェア
・企業別のフィルゴチニブの年間売上：2018-2023年の売上、市場シェア
・企業別のフィルゴチニブ販売価格
・主要企業のフィルゴチニブ生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

フィルゴチニブの地域別レビュー
・地域別のフィルゴチニブ市場規模2018-2023：年間販売量、売上
・主要国別のフィルゴチニブ市場規模2018-2023：年間販売量、売上
・南北アメリカのフィルゴチニブ販売の成長
・アジア太平洋のフィルゴチニブ販売の成長
・ヨーロッパのフィルゴチニブ販売の成長
・中東・アフリカのフィルゴチニブ販売の成長

南北アメリカ市場
・南北アメリカの国別のフィルゴチニブ販売量、売上（2018-2023）
・南北アメリカのフィルゴチニブの種類別販売量
・南北アメリカのフィルゴチニブの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のフィルゴチニブ販売量、売上（2018-2023）
・アジア太平洋のフィルゴチニブの種類別販売量
・アジア太平洋のフィルゴチニブの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のフィルゴチニブ販売量、売上（2018-2023）
・ヨーロッパのフィルゴチニブの種類別販売量
・ヨーロッパのフィルゴチニブの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のフィルゴチニブ販売量、売上（2018-2023）
・中東・アフリカのフィルゴチニブの種類別販売量
・中東・アフリカのフィルゴチニブの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・フィルゴチニブの製造コスト構造分析
・フィルゴチニブの製造プロセス分析
・フィルゴチニブの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・フィルゴチニブの主要なグローバル販売業者
・フィルゴチニブの主要なグローバル顧客

地域別のフィルゴチニブ市場予測レビュー
・地域別のフィルゴチニブ市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・フィルゴチニブの種類別市場規模予測
・フィルゴチニブの用途別市場規模予測

主要企業分析
Cayman Chemical、 BioVision、 Adooq Bioscience、 Taiclone、 Clearsynth、 Biorbyt、 APExBIO Technology、 Selleck Chemicals、 AbMole、 BOC Sciences、 TargetMol、 Toronto Research Chemicals、 J&K Scientific
・企業情報
・フィルゴチニブ製品
・フィルゴチニブ販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
LPI (LP Information)’ newest research report, the “Filgotinib Industry Forecast” looks at past sales and reviews total world Filgotinib sales in 2022, providing a comprehensive analysis by region and market sector of projected Filgotinib sales for 2023 through 2029. With Filgotinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Filgotinib industry.
This Insight Report provides a comprehensive analysis of the global Filgotinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Filgotinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Filgotinib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Filgotinib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Filgotinib.
The global Filgotinib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Filgotinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Filgotinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Filgotinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Filgotinib players cover Cayman Chemical, BioVision, Adooq Bioscience, Taiclone, Clearsynth, Biorbyt, APExBIO Technology, Selleck Chemicals and AbMole, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Filgotinib market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segmentation by application
Research
Medical
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Cayman Chemical
BioVision
Adooq Bioscience
Taiclone
Clearsynth
Biorbyt
APExBIO Technology
Selleck Chemicals
AbMole
BOC Sciences
TargetMol
Toronto Research Chemicals
J&K Scientific
Key Questions Addressed in this Report
What is the 10-year outlook for the global Filgotinib market?
What factors are driving Filgotinib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Filgotinib market opportunities vary by end market size?
How does Filgotinib break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Filgotinib Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Filgotinib by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Filgotinib by Country/Region, 2018, 2022 & 2029
2.2 Filgotinib Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Filgotinib Sales by Type
2.3.1 Global Filgotinib Sales Market Share by Type (2018-2023)
2.3.2 Global Filgotinib Revenue and Market Share by Type (2018-2023)
2.3.3 Global Filgotinib Sale Price by Type (2018-2023)
2.4 Filgotinib Segment by Application
2.4.1 Research
2.4.2 Medical
2.5 Filgotinib Sales by Application
2.5.1 Global Filgotinib Sale Market Share by Application (2018-2023)
2.5.2 Global Filgotinib Revenue and Market Share by Application (2018-2023)
2.5.3 Global Filgotinib Sale Price by Application (2018-2023)
3 Global Filgotinib by Company
3.1 Global Filgotinib Breakdown Data by Company
3.1.1 Global Filgotinib Annual Sales by Company (2018-2023)
3.1.2 Global Filgotinib Sales Market Share by Company (2018-2023)
3.2 Global Filgotinib Annual Revenue by Company (2018-2023)
3.2.1 Global Filgotinib Revenue by Company (2018-2023)
3.2.2 Global Filgotinib Revenue Market Share by Company (2018-2023)
3.3 Global Filgotinib Sale Price by Company
3.4 Key Manufacturers Filgotinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Filgotinib Product Location Distribution
3.4.2 Players Filgotinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Filgotinib by Geographic Region
4.1 World Historic Filgotinib Market Size by Geographic Region (2018-2023)
4.1.1 Global Filgotinib Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Filgotinib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Filgotinib Market Size by Country/Region (2018-2023)
4.2.1 Global Filgotinib Annual Sales by Country/Region (2018-2023)
4.2.2 Global Filgotinib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Filgotinib Sales Growth
4.4 APAC Filgotinib Sales Growth
4.5 Europe Filgotinib Sales Growth
4.6 Middle East & Africa Filgotinib Sales Growth
5 Americas
5.1 Americas Filgotinib Sales by Country
5.1.1 Americas Filgotinib Sales by Country (2018-2023)
5.1.2 Americas Filgotinib Revenue by Country (2018-2023)
5.2 Americas Filgotinib Sales by Type
5.3 Americas Filgotinib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Filgotinib Sales by Region
6.1.1 APAC Filgotinib Sales by Region (2018-2023)
6.1.2 APAC Filgotinib Revenue by Region (2018-2023)
6.2 APAC Filgotinib Sales by Type
6.3 APAC Filgotinib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Filgotinib by Country
7.1.1 Europe Filgotinib Sales by Country (2018-2023)
7.1.2 Europe Filgotinib Revenue by Country (2018-2023)
7.2 Europe Filgotinib Sales by Type
7.3 Europe Filgotinib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Filgotinib by Country
8.1.1 Middle East & Africa Filgotinib Sales by Country (2018-2023)
8.1.2 Middle East & Africa Filgotinib Revenue by Country (2018-2023)
8.2 Middle East & Africa Filgotinib Sales by Type
8.3 Middle East & Africa Filgotinib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Filgotinib
10.3 Manufacturing Process Analysis of Filgotinib
10.4 Industry Chain Structure of Filgotinib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Filgotinib Distributors
11.3 Filgotinib Customer
12 World Forecast Review for Filgotinib by Geographic Region
12.1 Global Filgotinib Market Size Forecast by Region
12.1.1 Global Filgotinib Forecast by Region (2024-2029)
12.1.2 Global Filgotinib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Filgotinib Forecast by Type
12.7 Global Filgotinib Forecast by Application
13 Key Players Analysis
13.1 Cayman Chemical
13.1.1 Cayman Chemical Company Information
13.1.2 Cayman Chemical Filgotinib Product Portfolios and Specifications
13.1.3 Cayman Chemical Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Cayman Chemical Main Business Overview
13.1.5 Cayman Chemical Latest Developments
13.2 BioVision
13.2.1 BioVision Company Information
13.2.2 BioVision Filgotinib Product Portfolios and Specifications
13.2.3 BioVision Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BioVision Main Business Overview
13.2.5 BioVision Latest Developments
13.3 Adooq Bioscience
13.3.1 Adooq Bioscience Company Information
13.3.2 Adooq Bioscience Filgotinib Product Portfolios and Specifications
13.3.3 Adooq Bioscience Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Adooq Bioscience Main Business Overview
13.3.5 Adooq Bioscience Latest Developments
13.4 Taiclone
13.4.1 Taiclone Company Information
13.4.2 Taiclone Filgotinib Product Portfolios and Specifications
13.4.3 Taiclone Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Taiclone Main Business Overview
13.4.5 Taiclone Latest Developments
13.5 Clearsynth
13.5.1 Clearsynth Company Information
13.5.2 Clearsynth Filgotinib Product Portfolios and Specifications
13.5.3 Clearsynth Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Clearsynth Main Business Overview
13.5.5 Clearsynth Latest Developments
13.6 Biorbyt
13.6.1 Biorbyt Company Information
13.6.2 Biorbyt Filgotinib Product Portfolios and Specifications
13.6.3 Biorbyt Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Biorbyt Main Business Overview
13.6.5 Biorbyt Latest Developments
13.7 APExBIO Technology
13.7.1 APExBIO Technology Company Information
13.7.2 APExBIO Technology Filgotinib Product Portfolios and Specifications
13.7.3 APExBIO Technology Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 APExBIO Technology Main Business Overview
13.7.5 APExBIO Technology Latest Developments
13.8 Selleck Chemicals
13.8.1 Selleck Chemicals Company Information
13.8.2 Selleck Chemicals Filgotinib Product Portfolios and Specifications
13.8.3 Selleck Chemicals Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Selleck Chemicals Main Business Overview
13.8.5 Selleck Chemicals Latest Developments
13.9 AbMole
13.9.1 AbMole Company Information
13.9.2 AbMole Filgotinib Product Portfolios and Specifications
13.9.3 AbMole Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 AbMole Main Business Overview
13.9.5 AbMole Latest Developments
13.10 BOC Sciences
13.10.1 BOC Sciences Company Information
13.10.2 BOC Sciences Filgotinib Product Portfolios and Specifications
13.10.3 BOC Sciences Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 BOC Sciences Main Business Overview
13.10.5 BOC Sciences Latest Developments
13.11 TargetMol
13.11.1 TargetMol Company Information
13.11.2 TargetMol Filgotinib Product Portfolios and Specifications
13.11.3 TargetMol Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 TargetMol Main Business Overview
13.11.5 TargetMol Latest Developments
13.12 Toronto Research Chemicals
13.12.1 Toronto Research Chemicals Company Information
13.12.2 Toronto Research Chemicals Filgotinib Product Portfolios and Specifications
13.12.3 Toronto Research Chemicals Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Toronto Research Chemicals Main Business Overview
13.12.5 Toronto Research Chemicals Latest Developments
13.13 J&K Scientific
13.13.1 J&K Scientific Company Information
13.13.2 J&K Scientific Filgotinib Product Portfolios and Specifications
13.13.3 J&K Scientific Filgotinib Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 J&K Scientific Main Business Overview
13.13.5 J&K Scientific Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Filgotinib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Filgotinib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Filgotinib Sales by Type (2018-2023) & (Kg)
Table 7. Global Filgotinib Sales Market Share by Type (2018-2023)
Table 8. Global Filgotinib Revenue by Type (2018-2023) & ($ million)
Table 9. Global Filgotinib Revenue Market Share by Type (2018-2023)
Table 10. Global Filgotinib Sale Price by Type (2018-2023) & (K USD/Kg)
Table 11. Global Filgotinib Sales by Application (2018-2023) & (Kg)
Table 12. Global Filgotinib Sales Market Share by Application (2018-2023)
Table 13. Global Filgotinib Revenue by Application (2018-2023)
Table 14. Global Filgotinib Revenue Market Share by Application (2018-2023)
Table 15. Global Filgotinib Sale Price by Application (2018-2023) & (K USD/Kg)
Table 16. Global Filgotinib Sales by Company (2018-2023) & (Kg)
Table 17. Global Filgotinib Sales Market Share by Company (2018-2023)
Table 18. Global Filgotinib Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Filgotinib Revenue Market Share by Company (2018-2023)
Table 20. Global Filgotinib Sale Price by Company (2018-2023) & (K USD/Kg)
Table 21. Key Manufacturers Filgotinib Producing Area Distribution and Sales Area
Table 22. Players Filgotinib Products Offered
Table 23. Filgotinib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Filgotinib Sales by Geographic Region (2018-2023) & (Kg)
Table 27. Global Filgotinib Sales Market Share Geographic Region (2018-2023)
Table 28. Global Filgotinib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Filgotinib Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Filgotinib Sales by Country/Region (2018-2023) & (Kg)
Table 31. Global Filgotinib Sales Market Share by Country/Region (2018-2023)
Table 32. Global Filgotinib Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Filgotinib Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Filgotinib Sales by Country (2018-2023) & (Kg)
Table 35. Americas Filgotinib Sales Market Share by Country (2018-2023)
Table 36. Americas Filgotinib Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Filgotinib Revenue Market Share by Country (2018-2023)
Table 38. Americas Filgotinib Sales by Type (2018-2023) & (Kg)
Table 39. Americas Filgotinib Sales by Application (2018-2023) & (Kg)
Table 40. APAC Filgotinib Sales by Region (2018-2023) & (Kg)
Table 41. APAC Filgotinib Sales Market Share by Region (2018-2023)
Table 42. APAC Filgotinib Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Filgotinib Revenue Market Share by Region (2018-2023)
Table 44. APAC Filgotinib Sales by Type (2018-2023) & (Kg)
Table 45. APAC Filgotinib Sales by Application (2018-2023) & (Kg)
Table 46. Europe Filgotinib Sales by Country (2018-2023) & (Kg)
Table 47. Europe Filgotinib Sales Market Share by Country (2018-2023)
Table 48. Europe Filgotinib Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Filgotinib Revenue Market Share by Country (2018-2023)
Table 50. Europe Filgotinib Sales by Type (2018-2023) & (Kg)
Table 51. Europe Filgotinib Sales by Application (2018-2023) & (Kg)
Table 52. Middle East & Africa Filgotinib Sales by Country (2018-2023) & (Kg)
Table 53. Middle East & Africa Filgotinib Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Filgotinib Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Filgotinib Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Filgotinib Sales by Type (2018-2023) & (Kg)
Table 57. Middle East & Africa Filgotinib Sales by Application (2018-2023) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Filgotinib
Table 59. Key Market Challenges & Risks of Filgotinib
Table 60. Key Industry Trends of Filgotinib
Table 61. Filgotinib Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Filgotinib Distributors List
Table 64. Filgotinib Customer List
Table 65. Global Filgotinib Sales Forecast by Region (2024-2029) & (Kg)
Table 66. Global Filgotinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Filgotinib Sales Forecast by Country (2024-2029) & (Kg)
Table 68. Americas Filgotinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Filgotinib Sales Forecast by Region (2024-2029) & (Kg)
Table 70. APAC Filgotinib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Filgotinib Sales Forecast by Country (2024-2029) & (Kg)
Table 72. Europe Filgotinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Filgotinib Sales Forecast by Country (2024-2029) & (Kg)
Table 74. Middle East & Africa Filgotinib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Filgotinib Sales Forecast by Type (2024-2029) & (Kg)
Table 76. Global Filgotinib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Filgotinib Sales Forecast by Application (2024-2029) & (Kg)
Table 78. Global Filgotinib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Cayman Chemical Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 80. Cayman Chemical Filgotinib Product Portfolios and Specifications
Table 81. Cayman Chemical Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 82. Cayman Chemical Main Business
Table 83. Cayman Chemical Latest Developments
Table 84. BioVision Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 85. BioVision Filgotinib Product Portfolios and Specifications
Table 86. BioVision Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 87. BioVision Main Business
Table 88. BioVision Latest Developments
Table 89. Adooq Bioscience Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 90. Adooq Bioscience Filgotinib Product Portfolios and Specifications
Table 91. Adooq Bioscience Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 92. Adooq Bioscience Main Business
Table 93. Adooq Bioscience Latest Developments
Table 94. Taiclone Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 95. Taiclone Filgotinib Product Portfolios and Specifications
Table 96. Taiclone Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 97. Taiclone Main Business
Table 98. Taiclone Latest Developments
Table 99. Clearsynth Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 100. Clearsynth Filgotinib Product Portfolios and Specifications
Table 101. Clearsynth Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 102. Clearsynth Main Business
Table 103. Clearsynth Latest Developments
Table 104. Biorbyt Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 105. Biorbyt Filgotinib Product Portfolios and Specifications
Table 106. Biorbyt Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 107. Biorbyt Main Business
Table 108. Biorbyt Latest Developments
Table 109. APExBIO Technology Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 110. APExBIO Technology Filgotinib Product Portfolios and Specifications
Table 111. APExBIO Technology Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 112. APExBIO Technology Main Business
Table 113. APExBIO Technology Latest Developments
Table 114. Selleck Chemicals Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 115. Selleck Chemicals Filgotinib Product Portfolios and Specifications
Table 116. Selleck Chemicals Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 117. Selleck Chemicals Main Business
Table 118. Selleck Chemicals Latest Developments
Table 119. AbMole Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 120. AbMole Filgotinib Product Portfolios and Specifications
Table 121. AbMole Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 122. AbMole Main Business
Table 123. AbMole Latest Developments
Table 124. BOC Sciences Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 125. BOC Sciences Filgotinib Product Portfolios and Specifications
Table 126. BOC Sciences Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 127. BOC Sciences Main Business
Table 128. BOC Sciences Latest Developments
Table 129. TargetMol Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 130. TargetMol Filgotinib Product Portfolios and Specifications
Table 131. TargetMol Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 132. TargetMol Main Business
Table 133. TargetMol Latest Developments
Table 134. Toronto Research Chemicals Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 135. Toronto Research Chemicals Filgotinib Product Portfolios and Specifications
Table 136. Toronto Research Chemicals Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 137. Toronto Research Chemicals Main Business
Table 138. Toronto Research Chemicals Latest Developments
Table 139. J&K Scientific Basic Information, Filgotinib Manufacturing Base, Sales Area and Its Competitors
Table 140. J&K Scientific Filgotinib Product Portfolios and Specifications
Table 141. J&K Scientific Filgotinib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 142. J&K Scientific Main Business
Table 143. J&K Scientific Latest Developments
List of Figures
Figure 1. Picture of Filgotinib
Figure 2. Filgotinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Filgotinib Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Filgotinib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Filgotinib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Filgotinib Sales Market Share by Type in 2022
Figure 13. Global Filgotinib Revenue Market Share by Type (2018-2023)
Figure 14. Filgotinib Consumed in Research
Figure 15. Global Filgotinib Market: Research (2018-2023) & (Kg)
Figure 16. Filgotinib Consumed in Medical
Figure 17. Global Filgotinib Market: Medical (2018-2023) & (Kg)
Figure 18. Global Filgotinib Sales Market Share by Application (2022)
Figure 19. Global Filgotinib Revenue Market Share by Application in 2022
Figure 20. Filgotinib Sales Market by Company in 2022 (Kg)
Figure 21. Global Filgotinib Sales Market Share by Company in 2022
Figure 22. Filgotinib Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Filgotinib Revenue Market Share by Company in 2022
Figure 24. Global Filgotinib Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Filgotinib Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Filgotinib Sales 2018-2023 (Kg)
Figure 27. Americas Filgotinib Revenue 2018-2023 ($ Millions)
Figure 28. APAC Filgotinib Sales 2018-2023 (Kg)
Figure 29. APAC Filgotinib Revenue 2018-2023 ($ Millions)
Figure 30. Europe Filgotinib Sales 2018-2023 (Kg)
Figure 31. Europe Filgotinib Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Filgotinib Sales 2018-2023 (Kg)
Figure 33. Middle East & Africa Filgotinib Revenue 2018-2023 ($ Millions)
Figure 34. Americas Filgotinib Sales Market Share by Country in 2022
Figure 35. Americas Filgotinib Revenue Market Share by Country in 2022
Figure 36. Americas Filgotinib Sales Market Share by Type (2018-2023)
Figure 37. Americas Filgotinib Sales Market Share by Application (2018-2023)
Figure 38. United States Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Filgotinib Sales Market Share by Region in 2022
Figure 43. APAC Filgotinib Revenue Market Share by Regions in 2022
Figure 44. APAC Filgotinib Sales Market Share by Type (2018-2023)
Figure 45. APAC Filgotinib Sales Market Share by Application (2018-2023)
Figure 46. China Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Filgotinib Sales Market Share by Country in 2022
Figure 54. Europe Filgotinib Revenue Market Share by Country in 2022
Figure 55. Europe Filgotinib Sales Market Share by Type (2018-2023)
Figure 56. Europe Filgotinib Sales Market Share by Application (2018-2023)
Figure 57. Germany Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Filgotinib Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Filgotinib Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Filgotinib Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Filgotinib Sales Market Share by Application (2018-2023)
Figure 66. Egypt Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Filgotinib Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Filgotinib in 2022
Figure 72. Manufacturing Process Analysis of Filgotinib
Figure 73. Industry Chain Structure of Filgotinib
Figure 74. Channels of Distribution
Figure 75. Global Filgotinib Sales Market Forecast by Region (2024-2029)
Figure 76. Global Filgotinib Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Filgotinib Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Filgotinib Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Filgotinib Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Filgotinib Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のフィルゴチニブ市場予測 2023年-2029年(Global Filgotinib Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のフィルゴチニブ市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp